BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260227T080000
DTEND;TZID=America/Halifax:20260227T170000
DTSTAMP:20260404T111708
CREATED:20260227T104948Z
LAST-MODIFIED:20260227T104948Z
UID:10000673-1772179200-1772211600@oncodaily.com
SUMMARY:5th Annual International Congress on Pediatric Oncology 2026
DESCRIPTION:The 5th Annual International Congress on Pediatric Oncology will be held virtually on November 6\, 2026. \nChaired by Dr. Jacqueline M. Kraveka of the Medical University of South Carolina\, this congress focuses on the rapid evolution of pediatric solid and hematologic malignancies. The program highlights clinical trial interpretations regarding novel targeted agents and immunotherapies\, alongside new techniques for molecular tumor characterization to improve outcomes for pediatric and adolescent/young adult (AYA) patients. Key highlights include focused sessions on navigating challenges in relapsed/refractory neuroblastoma\, the integration of CAR-T cell therapies\, and innovative strategies for managing late effects of treatment in survivorship care. \nRegister now.
URL:https://oncodaily.com/event/pediatric-oncology-462051
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-27T145029.279.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260227
DTEND;VALUE=DATE:20260301
DTSTAMP:20260404T111708
CREATED:20251213T232554Z
LAST-MODIFIED:20251213T232608Z
UID:10000486-1772150400-1772323199@oncodaily.com
SUMMARY:Updates on Advanced Breast Cancer: Local Management and Other New Perspectives
DESCRIPTION:The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day\, in-person event scheduled for February 27–28\, 2026\, at the Houston Marriott Medical Center in Houston\, TX. \nHosted by The University of Texas MD Anderson Cancer Center\, the activity’s main goal is to emphasize the integration of novel therapies and diagnostic tools into clinical practice\, focusing on areas like liquid biopsy\, ctDNA\, and MRD monitoring for inflammatory breast cancer (IBC). \nRegister.
URL:https://oncodaily.com/event/advanced-breast-cancer-427773
LOCATION:Houston Marriott Medical Center/Museum District\, 6580 Fannin Street\, Driveway Entrance on\, 1730 Dryden Rd\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/breast-cancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260226T090000
DTEND;TZID=America/Halifax:20260226T170000
DTSTAMP:20260404T111708
CREATED:20251123T182557Z
LAST-MODIFIED:20251123T182645Z
UID:10000391-1772096400-1772125200@oncodaily.com
SUMMARY:2026 Translating Evidence to Action: Elevating Cancer Care
DESCRIPTION:The “2026 Translating Evidence to Action: Elevating Cancer Care“ is an annual continuing medical education (CME) forum organized by Memorial Sloan Kettering Cancer Center (MSK)\, scheduled as a live virtual conference on Thursday\, February 26\, 2026. \nThis program is designed for healthcare professionals across all disciplines to explore how evidence-based research can be translated into meaningful quality improvements in clinical practice and patient outcomes. The conference features exemplary quality improvement projects\, practice-based initiatives\, two dynamic Rapid-Fire Poster Sessions\, and a keynote address on “Technology with a Human Pulse: Advancing Patient Care with Innovation and Intention.” Participants can earn up to 6.50 AMA PRA Category 1 Credits. \nRegister.
URL:https://oncodaily.com/event/translating-evidence-to-action-415021
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/MSK.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260226
DTEND;VALUE=DATE:20260301
DTSTAMP:20260404T111708
CREATED:20251022T222055Z
LAST-MODIFIED:20251022T222108Z
UID:10000286-1772064000-1772323199@oncodaily.com
SUMMARY:2026 ASCO GU Cancers Symposium
DESCRIPTION:The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28\, 2026\, at Moscone West in San Francisco\, California. \nThis premier event\, hosted by the American Society of Clinical Oncology (ASCO)\, will focus on the latest advancements in the prevention\, diagnosis\, and treatment of genitourinary cancers\, including prostate\, bladder\, kidney\, and testicular cancers. The symposium will feature groundbreaking research presentations\, expert-led educational sessions\, and in-depth discussions on key topics in GU oncology. \nAttendees can expect a rich program that combines plenary lectures\, oral abstract presentations\, poster sessions\, and interactive workshops. The event emphasizes multidisciplinary collaboration\, bringing together medical oncologists\, urologists\, radiation oncologists\, pathologists\, advanced practice providers\, nurses\, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology\, immunotherapy\, novel targeted therapies\, survivorship\, and health equity in GU cancers\, highlighting both scientific innovation and patient-centered care. \nThe symposium also offers networking opportunities with leading global experts\, enabling participants to exchange knowledge\, discuss challenges\, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available\, allowing wider access for international participants. \nRegistration. \nYou can find more posts featuring ASCO on OncoDaily.
URL:https://oncodaily.com/event/asco-396360
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/GU26.png
ORGANIZER;CN="American Society of Clinical Oncology":MAILTO:https://asco.org/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260226
DTEND;VALUE=DATE:20260227
DTSTAMP:20260404T111708
CREATED:20260222T122040Z
LAST-MODIFIED:20260222T122040Z
UID:10000662-1772064000-1772150399@oncodaily.com
SUMMARY:Radiotherapy Challenges in Locally Advanced NSCLC in the Neoadjuvant Era
DESCRIPTION:The International Association for the Study of Lung Cancer (IASLC) is hosting a webinar on February 26\, 2026\, titled “Radiotherapy Challenges in Locally Advanced Non-Small Cell Lung Cancer in the Neoadjuvant Era.”  \nAs Stage III NSCLC becomes a “moving target” due to the rapid integration of neoadjuvant chemo-immunotherapy\, this session aims to bridge critical practice gaps in multidisciplinary care. Led by world-renowned experts including Shankar Siva (Peter MacCallum Cancer Centre)\, Cecile Le Pechoux (Gustave Roussy)\, and Paul Martin Putora (St. Gallen)\, the webinar will provide pragmatic strategies for navigating contemporary mediastinal staging\, transitioning to definitive chemoradiotherapy when surgery is aborted\, and optimizing post-operative radiation. By synthesizing evidence-based principles with case-based discussions\, the event offers a vital framework for clinicians to deliver quality\, risk-adapted care in an increasingly complex therapeutic landscape. \nRegister now.
URL:https://oncodaily.com/event/nsclc-459497
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/Radiotherapy-Challenges-in-Locally-Advanced-Non-Small-Cell-Lung-Cancer-in-the-Neoadjuvant-Era.webp
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260225T103000
DTEND;TZID=America/Halifax:20260225T163000
DTSTAMP:20260404T111708
CREATED:20260216T122543Z
LAST-MODIFIED:20260216T123434Z
UID:10000654-1772015400-1772037000@oncodaily.com
SUMMARY:2nd Pediatric and Neonatal Palliative Care Symposium
DESCRIPTION:The 2nd Pediatric and Neonatal Palliative Care Symposium 2026\, organized by the CHANCE Association and endorsed by the Lebanese Association for Palliative Care Nursing\, will take place on February 25 at Fondation Charles Corm in Ashrafieh\, Beirut. \nThe scientific program begins at 11:00 AM\, featuring a keynote by Professor Julia Downing of the International Children’s Palliative Care Network on global perspectives in children’s palliative care. Sessions will focus on prenatal and neonatal palliation\, pediatric pain management\, innovation including virtual reality\, and a national panel assessing the current landscape of pediatric palliative care in Lebanon. \nAt 3:30 PM\, the event transitions to the Closing Event of the National Pioneer Project\, held under the patronage and in the presence of H.E. Minister of Public Health Dr. Rakan Nassereddine. Prof. Roula Farah\, President of CHANCE Association\, will formally present “Innovation and Immersive Technology in Pediatric Pain\, Psycho-Oncology and Palliative Care: Impact\, Voices\, and the Path Forward.” The ceremony will highlight project outcomes\, children and parents’ testimonials\, and recognition of psychologists and hospital partners who contributed to advancing pediatric psycho-oncology and palliative services nationwide. \nRegister now. \nRSVP: Confirm your attendance by calling 70-812259 or emailing chanceassociation@gmail.com \nSee the full agenda and program details.
URL:https://oncodaily.com/event/palliative-care-456410
LOCATION:Fondation Charles Corm\, Corm Building\, Beirut\, Lebanon
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-16T162442.814.webp
ORGANIZER;CN="Chance Association":MAILTO:chanceassociation@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260225T080000
DTEND;TZID=America/Halifax:20260225T170000
DTSTAMP:20260404T111708
CREATED:20260225T074820Z
LAST-MODIFIED:20260225T074820Z
UID:10000669-1772006400-1772038800@oncodaily.com
SUMMARY:EnVision Summit 2027
DESCRIPTION:The EnVision Summit 2027 is a premier multispecialty ophthalmology and optometry meeting scheduled for February 12–15\, 2027\, at the Hyatt Regency Grand Reserve Puerto Rico. \nCreated by physicians for physicians\, the summit breaks the traditional conference mold by offering a family-friendly “one-stop-shop” for CME and COPE credits in a relaxed\, resort setting. The 2027 program will feature dedicated tracks for cataract and refractive surgery\, glaucoma management\, retina\, and ocular surface disease\, with a strong emphasis on the clinical integration of Artificial Intelligence (AI) and multidisciplinary co-management. Unique to this event\, the complimentary Youth Track provides interactive programs for children while parents attend lectures\, ensuring a professional development experience that enhances work-life balance without sacrificing academic rigor. \nRegister now.
URL:https://oncodaily.com/event/envision-summit-460836
LOCATION:Hyatt Regency Grand Reserve\, 200 Coco Beach Blvd.\, Río Grande\, Puerto Rico\, 00745\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-25T114603.041.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260228
DTSTAMP:20260404T111708
CREATED:20260120T124959Z
LAST-MODIFIED:20260120T125010Z
UID:10000600-1771977600-1772236799@oncodaily.com
SUMMARY:62nd Annual Scientific Conference of the Irish Association for Cancer Research (IACR)
DESCRIPTION:The 62nd Annual Scientific Conference of the Irish Association for Cancer Research (IACR) is a prominent gathering of the Irish cancer research community\, scheduled for February 25–27\, 2026. Taking place at the Galway Bay Hotel in Salthill\, Galway\, the conference serves as a multidisciplinary platform for clinicians\, basic scientists\, and nursing professionals to discuss the latest advancements in oncology. \nKey themes for the 2026 meeting include digital and connected health applications\, liquid biopsies for disease monitoring\, and advanced tumor models. The event also highlights excellence in communication through the Patrick G. Johnston Award for Excellence in Cancer Research Outreach\, which encourages early-stage researchers to present their work to lay audiences\, bridging the gap between high-level science and public understanding. \nRegister.
URL:https://oncodaily.com/event/irish-association-for-cancer-research-444051
LOCATION:Galway Bay Hotel\, Salthill Road Lower\, Salthill\, Galway\, County Galway\, H91 W295\, Ireland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/IACR.webp
ORGANIZER;CN="Irish Association for Cancer Research (IACR)":MAILTO:+353 (0)1 295 8859
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260404T111708
CREATED:20260131T002619Z
LAST-MODIFIED:20260131T002640Z
UID:10000651-1771977600-1772063999@oncodaily.com
SUMMARY:British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop
DESCRIPTION:The British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop is scheduled for Wednesday\, February 25\, 2026\, in London. \nThis face-to-face event is designed for members of the haematology community with a specialist interest in supportive care – ranging from pain and infection management to psychological and social support – to meet and network in person. The primary objective of the workshop is to collaborate on developing the SIG’s strategy for the coming years\, ensuring that multidisciplinary expertise continues to improve education\, training\, and clinical practice for patients with blood disorders across the UK. \nChaired by Laura Miller\, the SIG committee includes a diverse group of professionals such as Shireen Kassam\, Priya Sriskandarajah\, and Jennifer Vidrine\, who will lead discussions on embedding high standards of supportive care throughout the patient treatment pathway.
URL:https://oncodaily.com/event/british-society-of-haematology-449715
LOCATION:Friends House in Euston\, 173-177 Euston Rd.\, London\, NW1 2BJ\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BSH.webp
ORGANIZER;CN="British Society of Haematology":MAILTO:info@b-s-h.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260404T111708
CREATED:20251126T002352Z
LAST-MODIFIED:20251126T002404Z
UID:10000404-1771977600-1772063999@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. \nThe webinar will be broadcast live virtually on February 25\, 2026\, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice\, such as optimal biomarker testing\, the integration of immunotherapy\, and the management of treatment-related toxicities. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-416474
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260404T111708
CREATED:20251222T221627Z
LAST-MODIFIED:20251222T221637Z
UID:10000523-1771891200-1772150399@oncodaily.com
SUMMARY:Data-Driven Cancer Research Conference
DESCRIPTION:The Data-Driven Cancer Research Conference is a comprehensive three-day scientific event hosted by Cancer Research UK in partnership with the EACR (European Association for Cancer Research)\, scheduled for February 24–26\, 2026. \nSet in the historic city of Edinburgh\, the conference explores the intersection of data science and oncology\, featuring expert-led discussions on AI-accelerated early detection\, digital twins\, and inclusive precision medicine. The program aims to foster global collaboration among bioinformaticians\, computational oncologists\, and researchers to address shared challenges in patient data transparency and pediatric cancer. \nRegister.
URL:https://oncodaily.com/event/data-driven-cancer-research-432826
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison St\, Edinburgh\, EH3 8EE
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/EACR.webp
ORGANIZER;CN="Cancer Research UK":MAILTO:supporter.services@cancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260404T111708
CREATED:20251213T014339Z
LAST-MODIFIED:20251213T014358Z
UID:10000485-1771891200-1772150399@oncodaily.com
SUMMARY:Colorectal Liver Metastasis Consensus Conference
DESCRIPTION:The Colorectal Liver Metastasis Consensus Conference\, based on the Danish-Zurich model\, is a three-day in-person conference dedicated to advancing care\, research\, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday\, February 24\, to Thursday\, February 26\, 2026\, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) in Houston\, Texas. \nHosted by The University of Texas MD Anderson Cancer Center\, the primary goal is to establish guidelines for the treatment of and research related to colorectal cancer liver metastases\, culminating in a consensus statement brought forth by leading experts\, clinicians\, and researchers in the field. \nRegister.
URL:https://oncodaily.com/event/colorectal-liver-metastasis426895
LOCATION:TMC3 Collaborative Building\, 7255 Helix Park Ave\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/md.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260404T111708
CREATED:20251110T130152Z
LAST-MODIFIED:20260304T124024Z
UID:10000334-1771891200-1772150399@oncodaily.com
SUMMARY:9th CAR-TCR Summit Europe 2026
DESCRIPTION:The 9th CAR-TCR Summit Europe 2026 is the essential\, industry-dedicated forum for next-generation cell therapy\, scheduled from February 24–26\, 2026\, in London\, UK\, at the Park Plaza Victoria hotel. Organized by Hanson Wade\, the summit unites developers from Europe and Asia with an end-to-end focus on accelerating clinical success by exploring cutting-edge scientific insights and practical strategies\, including novel CAR\, TCR\, NK\, and Macrophage designs\, engineering to improve durability\, and solutions to overcome bottlenecks in manufacturing\, regulatory approval\, and commercialization. \nFull Event Guide Link. \nThis article is sponsored by Hanson Wade Group.
URL:https://oncodaily.com/event/car-tcr-summit-406640
LOCATION:Park Plaza Victoria London\, 239 Vauxhall Bridge Road\, London\, Greater London (England)\, SW1V 1EQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/9th-CAR-TCR-Summit-Europe-2026.png
ORGANIZER;CN="Hanson Wade Limited":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260226
DTSTAMP:20260404T111708
CREATED:20251109T185330Z
LAST-MODIFIED:20251109T185345Z
UID:10000333-1771891200-1772063999@oncodaily.com
SUMMARY:Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
DESCRIPTION:The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic\, scheduled for February 24–25\, 2026. \nThe two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy\, spanning from basic research to clinical applications\, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment. \nThe program will feature invited talks from leading scientists on innovative therapeutic strategies\, including novel NK\, T\, and myeloid cell therapies\, mRNA therapies\, cytokine targeting\, and new combinatorial immune checkpoint blockade strategies.
URL:https://oncodaily.com/event/next-generation-immunotherapies-406112
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/EACR-2.jpg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
DTSTAMP:20260404T111708
CREATED:20260126T225512Z
LAST-MODIFIED:20260126T225524Z
UID:10000631-1771891200-1771977599@oncodaily.com
SUMMARY:Innovations and Clinical Advances in Radioligand Therapy
DESCRIPTION:The OncoCorner webinar\, titled “Innovations and clinical advances in radioligand therapy\,” is scheduled for Tuesday\, February 24\, 2026\, starting at 18:00 CET. This session explores the rapid evolution of Radioligand Therapy (RLT)\, focusing on how translational research is enhancing targeting precision and integrating nuclear medicine more deeply into modern oncology. \nParticipants will gain insights into current capabilities at leading cancer centers\, expected breakthroughs over the next several years\, and the most promising emerging agents in the RLT landscape. The event features an expert panel consisting of Antoine Leimgruber\, Saverio Braccini\, Anne-Laure Giraudet\, and Niklaus Schaefer\, and is supported by Sharing Progress in Cancer Care (SPCC) as part of its Sustaining Corporate Programme.
URL:https://oncodaily.com/event/radioligand-therapy-447592
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SPCC-6.webp
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260223
DTEND;VALUE=DATE:20260227
DTSTAMP:20260404T111708
CREATED:20251031T111100Z
LAST-MODIFIED:20251117T094309Z
UID:10000304-1771804800-1772150399@oncodaily.com
SUMMARY:16th World ADC London
DESCRIPTION:The 16th World ADC London\, set to convene at ExCeL London from February 23–26\, 2026\, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 event is differentiation across the ADC value chain – from design to production – in response to the dominance of Topo1 and MMAE payloads and the rising threat of resistance. \nThe summit will host over 800 senior European ADC decision-makers\, including biopharma executives\, clinicians\, investors\, and regulators. The comprehensive agenda features five streams covering the entire lifecycle of ADCs\, specifically highlighting novel cytotoxic and non-cytotoxic payloads\, dual/bispecific ADCs\, non-antibody conjugates\, and strategies for advancing these targeted therapies into earlier-line oncology treatments for maximum patient impact. \nThe 16th World ADC London event is expected to feature 800+ ADC Industry Attendees representing 240+ Companies in the Room\, with presentations delivered by a 120+ Global Speaker Faculty. The agenda includes 14+ Hours of Networking\, offering comprehensive One-on-One Partnering and informal networking opportunities\, spread across 4 Days of ADC Insights. The content is organized into 5 Tracks of End-to-End ADC Content. \nView the 2026 agenda here. \nRegistration link. \nFull Event Guide link. \nYou can find more posts on ADCs on OncoDaily.
URL:https://oncodaily.com/event/world-adc-london-401035
LOCATION:ExCeL London\, One Western Gateway\, Royal Victoria Dock\, London\, E16 1XL\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/World-ADC-London-Banner.jpg
ORGANIZER;CN="Hanson Wade Limited":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260220T090000
DTEND;TZID=America/New_York:20260220T100000
DTSTAMP:20260404T111708
CREATED:20260124T234805Z
LAST-MODIFIED:20260124T234834Z
UID:10000619-1771578000-1771581600@oncodaily.com
SUMMARY:CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia - Resonance
DESCRIPTION:The ALRCaN Global webinar\, titled “CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia\,” is scheduled for Friday\, February 20\, 2026\, at 09:00 AM ET. Featuring Dr. Hannah Lust\, the session will focus on the evolving treatment landscape for Adolescent and Young Adult (AYA) patients\, specifically examining the transition and relationship between CAR T-cell therapy and hematopoietic stem cell transplantation. \nHosted by Resonance Health and created by Ivana Cáceres\, the event is supported by the leadership of Scott Howard\, Stacy Cooper\, Archie Bleyer\, and Dan Douer. This discussion provides a global forum for oncology professionals to explore integrated therapeutic strategies aimed at optimizing long-term outcomes for the AYA leukemia population.
URL:https://oncodaily.com/event/car-t-cell-therapy-446541
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Hannah-Lust.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251224T105230Z
LAST-MODIFIED:20251224T105245Z
UID:10000524-1771545600-1771718399@oncodaily.com
SUMMARY:5th CECOG Breast Cancer Academy
DESCRIPTION:The 5th CECOG Breast Cancer Academy\, organized by the Central European Cooperative Oncology Group (CECOG)\, is a specialized educational event taking place on February 20-21\, 2026\, in Vienna\, Austria. \nHeld at the ARCOTEL AQ\, the academy is designed for oncology professionals to explore current standards and emerging challenges in both early and advanced breast cancer management. Led by a scientific committee of Austrian experts\, the program features expert-led sessions on clinical scenarios and offers CME accreditation to enhance the professional development of its participants.
URL:https://oncodaily.com/event/cecog-breast-cancer-433294
LOCATION:ARCOTEL AQ\, Althanstraße 8\, Vienna\, Vienna\, 1090\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/CECOG.webp
ORGANIZER;CN="Central European Cooperative Oncology Group (CECOG)":MAILTO:office@cecog.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251215T185942Z
LAST-MODIFIED:20251215T185950Z
UID:10000497-1771545600-1771718399@oncodaily.com
SUMMARY:Oncology APP Leadership Forum 2026
DESCRIPTION:The Oncology APP Leadership Forum 2026 is the 3rd annual two-day conference designed for current and aspiring Advanced Practice Provider (APP) leaders\, managers\, administrators\, and directors in oncology. \nScheduled for February 20–21\, 2026\, at the Circa Resort and Casino in Las Vegas\, the forum focuses on equipping APP leaders with the knowledge and skills to become more effective leaders in their organizations. Key topics on the agenda include critical conversations in the workplace\, utilizing AI in leadership\, constructing an APP billing dashboard\, building leadership education frameworks\, and a workshop on burnout and boundary setting. \nRegister.
URL:https://oncodaily.com/event/oncology-app-leadership-forum-429017
LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Oncology-APP-Leadership-Forum-2026.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251209T213259Z
LAST-MODIFIED:20251209T213315Z
UID:10000467-1771545600-1771718399@oncodaily.com
SUMMARY:Highlights in GI Oncology
DESCRIPTION:The Highlights in GI Oncology conference\, hosted by Horizon CME\, is a two-day educational program providing the latest science and practice-changing advances from the world’s premier GI oncology event\, the ASCO Gastrointestinal Cancers Symposium. \nThe CME initiative\, designed for a multidisciplinary audience including oncologists\, surgeons\, and nurses\, is scheduled for February 20–21\, 2026\, at the Orlando World Center Marriott. Expert faculty will review the most recent research and treatment strategies for various GI cancers\, including colorectal\, pancreatic\, biliary\, and neuroendocrine cancers\, applying the findings to patient case contexts. \nRegister.
URL:https://oncodaily.com/event/highlights-in-gi-oncology-425076
LOCATION:Orlando World Center Marriott\, 8701 World Center Dr\, Orlando\, FL\, 32821\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Screenshot-2025-12-10-013028.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260220
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251201T203902Z
LAST-MODIFIED:20251201T203902Z
UID:10000435-1771545600-1771718399@oncodaily.com
SUMMARY:APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit
DESCRIPTION:The APPOS Las Vegas 2026: Advanced Practice Providers Oncology Summit is a two-day continuing medical education conference organized by Horizon CME\, scheduled for February 20th – 21st\, 2026\, at the Circa Resort and Casino in Las Vegas\, Nevada. \nThe summit is specifically tailored for Advanced Practice Providers (APPs)\, including Nurse Practitioners (NPs)\, Physician Assistants (PAs)\, pharmacists\, and nurses\, with the primary goal of providing the latest evidence-based strategies to optimize care and outcomes for patients with cancer. \nRegister.
URL:https://oncodaily.com/event/419963
LOCATION:Circa Resort & Casino\, 8 Fremont St\, Las Vegas\, NV\, 89101\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/APPOS-Las-Vegas.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260219T190000
DTEND;TZID=America/New_York:20260219T200000
DTSTAMP:20260404T111708
CREATED:20260126T012807Z
LAST-MODIFIED:20260126T012831Z
UID:10000626-1771527600-1771531200@oncodaily.com
SUMMARY:Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care
DESCRIPTION:The Multinational Association of Supportive Care in Cancer (MASCC)\, in partnership with SIOG-NAHS and JASCC Geriatrics\, will host a webinar titled “Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care“. \nScheduled for Thursday\, February 19\, 2026\, the session runs from 7:00 PM to 8:00 PM EST. The agenda includes discussions on geriatric assessment in Japan and evidence-based integrative medicine\, featuring a panel led by co-chairs Dr. Ayumu Matsuoka and Dr. Sriram Yennu\, alongside Dr. Lisa Guccione and Dr. Kelly McConnell.
URL:https://oncodaily.com/event/geriatric-oncology-447041
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/MASCC-1.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260219T120000
DTEND;TZID=America/Halifax:20260219T130000
DTSTAMP:20260404T111708
CREATED:20251210T223125Z
LAST-MODIFIED:20251210T223148Z
UID:10000471-1771502400-1771506000@oncodaily.com
SUMMARY:Advocates Webinar: Modernizing Oncology Endpoints
DESCRIPTION:The Advocates Webinar: Modernizing Oncology Endpoints\, hosted virtually by Friends of Cancer Research (Friends)\, is a free\, advocates-focused session scheduled for Thursday\, February 19\, 2026\, from 12:00 PM to 1:00 PM ET. \nThe webinar will build upon the public meeting held earlier in the month\, focusing on translating complex scientific and policy discussions into accessible\, advocacy-focused insights concerning two emerging tools in cancer drug development: circulating tumor DNA (ctDNA) and Artificial Intelligence (AI)-based tumor assessment tools. The goal is to explain how these biomarkers and technologies can accelerate evidence generation and clinical trial efficiency to support earlier patient access to treatments. \nRegister.
URL:https://oncodaily.com/event/advocates-webinar-425835
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/webinar.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260219
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251026T210410Z
LAST-MODIFIED:20251026T210435Z
UID:10000291-1771459200-1771718399@oncodaily.com
SUMMARY:2026 Multidisciplinary Head and Neck Cancers Symposium by ASTRO
DESCRIPTION:The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day event scheduled for February 19-21\, 2026. Organized by ASTRO (American Society for Radiation Oncology) and co-sponsored by other key medical societies\, the symposium will be held both in-person in Palm Desert\, California\, and as a live virtual meeting online. \nThe central theme for the 2026 meeting is “Advancing Patient-Centered Care Through Innovative Team Science.” The conference aims to foster meaningful collaboration among radiation oncologists\, medical oncologists\, surgeons\, and other specialists to share the most current\, evidence-based practices in the field. \nThe program is structured to deliver practical insights through educational sessions\, interactive case discussions\, and oral abstract presentations. It serves as a forum for presenting and discussing new data\, with the Call for Abstracts remaining open until October 8\, 2025. The core objective of the symposium is to improve patient outcomes by advancing multidisciplinary treatment approaches and team-based care for head and neck cancers. Registration and housing are currently open for attendees.
URL:https://oncodaily.com/event/head-and-neck-cancers-398768
LOCATION:JW Marriott Desert Springs Resort and Spa\, 74-855 Country Club Dr.\, Palm Desert\, CA\, 92260\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/image-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260218T081500
DTEND;TZID=America/Halifax:20260220T190000
DTSTAMP:20260404T111708
CREATED:20251213T013628Z
LAST-MODIFIED:20251213T013743Z
UID:10000484-1771402500-1771614000@oncodaily.com
SUMMARY:2026 International Cancer Neuroscience Symposium
DESCRIPTION:The 2026 International Cancer Neuroscience Symposium\, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley’s Advanced Portfolio\, is a three-day dynamic hybrid event scheduled for Wednesday\, February 18\, to Friday\, February 20\, 2026. \nThe in-person component will be held at the TMC3 Collaborative Building in Houston\, Texas. This biennial symposium aims to integrate the fields of oncology\, neuroscience\, cancer biology\, neuroimmunology\, and mental health\, bringing together over 30 leading international experts to share key insights and cutting-edge research to foster innovation in cancer research and enhance patient care. \nRegister.
URL:https://oncodaily.com/event/international-cancer-neuroscience-symposium-426891
LOCATION:TMC3 Collaborative Building\, 7255 Helix Park Ave\, Houston\, TX\, 77030\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/1754434517156.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260218T080000
DTEND;TZID=America/Halifax:20260221T170000
DTSTAMP:20260404T111708
CREATED:20250717T130123Z
LAST-MODIFIED:20250717T130143Z
UID:10000220-1771401600-1771693200@oncodaily.com
SUMMARY:AACR IO Conference 2026
DESCRIPTION:The AACR IO Conference 2026\, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy\, will take place from February 18–21\, 2026\, at JW Marriott Los Angeles L.A. Live.  \nLed by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas\, the event will focus on cutting-edge research in cancer immunology\, highlighting breakthroughs in immuno-oncology (IO) drugs\, inflammatory modulators\, vaccines\, and cellular therapies. \nBuilding on the success of AACR IO 2025\, which drew over 600 participants\, AACR IO 2026 promises a comprehensive program including keynote lectures\, symposia\, spotlight sessions\, educational content\, and poster presentations. This forum offers a valuable opportunity for scientists\, clinicians\, industry leaders\, and advocates to engage with the latest advances in cancer immunotherapy. \nMore posts featuring AACR.
URL:https://oncodaily.com/event/aacr-io-conference-2026-331172
LOCATION:JW Marriott Los Angeles L.A. Live\, 900 W Olympic Blvd\, Los Angeles\, CA\, Los Angeles\, 90015\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/07/download-7.png
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251222T215456Z
LAST-MODIFIED:20251222T215529Z
UID:10000521-1771372800-1771718399@oncodaily.com
SUMMARY:Targeted Therapies of Lung Cancer (TTLC 2026)
DESCRIPTION:The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) meeting is a premier international conference scheduled for February 18–21\, 2026\, in Huntington Beach\, California. \nOrganized by the International Association for the Study of Lung Cancer (IASLC)\, this landmark event brings together global experts\, clinicians\, and researchers to share the latest breakthroughs in preclinical research and data from cutting-edge clinical trials. The symposium serves as a critical forum for discussing how emerging molecular targets and novel treatments are actively transforming clinical practice and treatment guidelines for thoracic malignancies. \nRegister.
URL:https://oncodaily.com/event/targeted-therapies-of-lung-cancer-432816
LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/TTLC-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260222
DTSTAMP:20260404T111708
CREATED:20251102T220138Z
LAST-MODIFIED:20251102T220151Z
UID:10000308-1771372800-1771718399@oncodaily.com
SUMMARY:Targeted Therapies of Lung Cancer 2026
DESCRIPTION:The Targeted Therapies of Lung Cancer (TTLC) 2026 Meeting\, organized by the International Association for the Study of Lung Cancer (IASLC)\, is a premier event for experts dedicated to advancing lung cancer care. The meeting is scheduled to begin on February 18\, 2026\, and will be held in Huntington Beach\, California. The conference is a must-attend event that brings together leading researchers\, clinicians\, and industry experts to share the latest breakthroughs in clinical research\, focusing on innovation in targeted therapies for thoracic malignancies. \nYou can find more posts featuring IASLC on OncoDaily.
URL:https://oncodaily.com/event/targeted-therapies-402227
LOCATION:Hyatt Regency Huntington Beach Resort And Spa\, 21500 Pacific Coast Hwy\, Huntington Beach\, CA\, 92648\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/10/IASLC.jpg
ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260221
DTSTAMP:20260404T111708
CREATED:20260126T011556Z
LAST-MODIFIED:20260126T011603Z
UID:10000624-1771372800-1771631999@oncodaily.com
SUMMARY:Advancing Cancer Research for Latinos and All Populations
DESCRIPTION:The Advancing Cancer Research for Latinos and All Populations conference is a biennial international event scheduled for February 18-20\, 2026\, in San Antonio\, Texas. \nHosted by the Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio\, this conference addresses the critical health disparities facing Latinos\, for whom cancer remains a leading cause of death\, and who often face significant barriers to screening\, treatment\, and palliative care. The summit unites a diverse group of stakeholders – including survivors\, caregivers\, researchers\, and physicians – to translate basic research into clinical best practices and effective community interventions. \nRegister.
URL:https://oncodaily.com/event/advancing-cancer-research-447028
LOCATION:Plaza San Antonio Hotel & Spa\, Autograph Collection\, 555 S Alamo St\, San Antonio\, TX\, 78205\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Latinos.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260404T111708
CREATED:20251126T002120Z
LAST-MODIFIED:20251126T002132Z
UID:10000403-1771372800-1771545599@oncodaily.com
SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply.
URL:https://oncodaily.com/event/esmo-preceptorship-416470
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR